0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Regenerative Medicine Market Size, Status and Forecast 2021-2027
Published Date: June 2021
|
Report Code: QYRE-Othe-373
Home | Market Reports | Health
Global Regenerative Medicine Market Size Status and Forecast 2021 2027

Global Regenerative Medicine Market Size, Status and Forecast 2021-2027

Code: QYRE-Othe-373
Report
June 2021
126 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Regenerative Medicine Market Statistics 2027

The global Regenerative Medicine market size is projected to reach US$ 116810 million by 2027, from US$ 33730 million in 2020, at a CAGR of 19.4% during 2021-2027. Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases. Currently, some companies in the world can provide regenerative medicine service, mainly concentrating in USA. The main market players are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, etc.
Regenerative Medicine Market
 
USA is the largest market of regenerative medicine, which occupies 51.09 percent of global regenerative medicine market share in 2015. It is followed by EU, which has around 16.66 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
According to the research, the most potential market in the main countries of regenerative medicine industry is Asia, determined by the rising level of medical care. Besides, South America, Middle East should also be focused by the investors. They are the potential consumers of regenerative medicine.
Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.
The relatively-mature technology is cell transplantation; tissue engineering and therapeutic cloning has its technical advantages, which is the direction of future research and development.

Regenerative Medicine Market Analysis And Insight

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Regenerative Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Regenerative Medicine market in terms of revenue.
Regenerative Medicine Market Size
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Regenerative Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Regenerative Medicine market.

Regenerative Medicine Market Size

Regenerative Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Regenerative Medicine Market By Type

  • Cell Therapy
  • Tissue Engineering
  • Biomaterial
  • Other

Regenerative Medicine Market By Application

  • Dermatology
  • Cardiovascular
  • CNS
  • Orthopedic
  • Others

Regenerative Medicine Market By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Regenerative Medicine Market By Company

  • DePuy Synthes
  • Medtronic
  • ZimmerBiomet
  • Stryker
  • Acelity
  • MiMedx Group
  • Organogenesis
  • UniQure
  • Cellular Dynamics International
  • Osiris Therapeutics
  • Vcanbio
  • Gamida Cell
  • Golden Meditech
  • Cytori
  • Celgene
  • Vericel Corporation
  • Guanhao Biotech
  • Mesoblast
  • Stemcell Technologies
  • Bellicum Pharmaceuticals

Regenerative Medicine Market Scope

Report Metric

Details

Report Name

 Regenerative Medicine Market

The Market size value in 2020

33730 Million USD

The Revenue forecast in 2027

116810 Million USD

Growth Rate

CAGR of 19.4% from 2021 to 2027

Base year considered

2020

Forecast period

2021-2027

Forecast units

Value (USD)

Segments covered

Type, End-User, Offerings, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Companies covered

DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals.

Frequently Asked Questions About This Report

1.How Big is the Regenerative Medicine Market?

Ans. The global Regenerative Medicine market size is projected to reach US$ 116810 million by 2027, from US$ 33730 million in 2020.

2. What is the Regenerative Medicine Market Growth?

Ans. The global Regenerative Medicine market is expected to grow at a compound annual growth rate of 19.4% from 2021 to 2027.

3. Who are the major key players in Regenerative Medicine Market?

Ans. DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2016-2027)
2.2 Regenerative Medicine Growth Trends by Regions
2.2.1 Regenerative Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Regenerative Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Regenerative Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Regenerative Medicine Industry Dynamic
2.3.1 Regenerative Medicine Market Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine Players by Revenue
3.1.1 Global Top Regenerative Medicine Players by Revenue (2016-2021)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2020
3.5 Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2016-2021)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2022-2027)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2016-2021)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Regenerative Medicine Market Size (2016-2027)
6.2 North America Regenerative Medicine Market Size by Type
6.2.1 North America Regenerative Medicine Market Size by Type (2016-2021)
6.2.2 North America Regenerative Medicine Market Size by Type (2022-2027)
6.2.3 North America Regenerative Medicine Market Size by Type (2016-2027)
6.3 North America Regenerative Medicine Market Size by Application
6.3.1 North America Regenerative Medicine Market Size by Application (2016-2021)
6.3.2 North America Regenerative Medicine Market Size by Application (2022-2027)
6.3.3 North America Regenerative Medicine Market Size by Application (2016-2027)
6.4 North America Regenerative Medicine Market Size by Country
6.4.1 North America Regenerative Medicine Market Size by Country (2016-2021)
6.4.2 North America Regenerative Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2016-2027)
7.2 Europe Regenerative Medicine Market Size by Type
7.2.1 Europe Regenerative Medicine Market Size by Type (2016-2021)
7.2.2 Europe Regenerative Medicine Market Size by Type (2022-2027)
7.2.3 Europe Regenerative Medicine Market Size by Type (2016-2027)
7.3 Europe Regenerative Medicine Market Size by Application
7.3.1 Europe Regenerative Medicine Market Size by Application (2016-2021)
7.3.2 Europe Regenerative Medicine Market Size by Application (2022-2027)
7.3.3 Europe Regenerative Medicine Market Size by Application (2016-2027)
7.4 Europe Regenerative Medicine Market Size by Country
7.4.1 Europe Regenerative Medicine Market Size by Country (2016-2021)
7.4.2 Europe Regenerative Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size (2016-2027)
8.2 Asia-Pacific Regenerative Medicine Market Size by Type
8.2.1 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Regenerative Medicine Market Size by Application
8.3.1 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Regenerative Medicine Market Size by Region
8.4.1 Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Regenerative Medicine Market Size (2016-2027)
9.2 Latin America Regenerative Medicine Market Size by Type
9.2.1 Latin America Regenerative Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Regenerative Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Regenerative Medicine Market Size by Type (2016-2027)
9.3 Latin America Regenerative Medicine Market Size by Application
9.3.1 Latin America Regenerative Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Regenerative Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Regenerative Medicine Market Size by Application (2016-2027)
9.4 Latin America Regenerative Medicine Market Size by Country
9.4.1 Latin America Regenerative Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Regenerative Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Market Size (2016-2027)
10.2 Middle East & Africa Regenerative Medicine Market Size by Type
10.2.1 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Regenerative Medicine Market Size by Application
10.3.1 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Regenerative Medicine Market Size by Country
10.4.1 Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 DePuy Synthes
11.1.1 DePuy Synthes Company Details
11.1.2 DePuy Synthes Business Overview
11.1.3 DePuy Synthes Regenerative Medicine Introduction
11.1.4 DePuy Synthes Revenue in Regenerative Medicine Business (2016-2021)
11.1.5 DePuy Synthes Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 ZimmerBiomet
11.3.1 ZimmerBiomet Company Details
11.3.2 ZimmerBiomet Business Overview
11.3.3 ZimmerBiomet Regenerative Medicine Introduction
11.3.4 ZimmerBiomet Revenue in Regenerative Medicine Business (2016-2021)
11.3.5 ZimmerBiomet Recent Development
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2016-2021)
11.4.5 Stryker Recent Development
11.5 Acelity
11.5.1 Acelity Company Details
11.5.2 Acelity Business Overview
11.5.3 Acelity Regenerative Medicine Introduction
11.5.4 Acelity Revenue in Regenerative Medicine Business (2016-2021)
11.5.5 Acelity Recent Development
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2016-2021)
11.6.5 MiMedx Group Recent Development
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2016-2021)
11.7.5 Organogenesis Recent Development
11.8 UniQure
11.8.1 UniQure Company Details
11.8.2 UniQure Business Overview
11.8.3 UniQure Regenerative Medicine Introduction
11.8.4 UniQure Revenue in Regenerative Medicine Business (2016-2021)
11.8.5 UniQure Recent Development
11.9 Cellular Dynamics International
11.9.1 Cellular Dynamics International Company Details
11.9.2 Cellular Dynamics International Business Overview
11.9.3 Cellular Dynamics International Regenerative Medicine Introduction
11.9.4 Cellular Dynamics International Revenue in Regenerative Medicine Business (2016-2021)
11.9.5 Cellular Dynamics International Recent Development
11.10 Osiris Therapeutics
11.10.1 Osiris Therapeutics Company Details
11.10.2 Osiris Therapeutics Business Overview
11.10.3 Osiris Therapeutics Regenerative Medicine Introduction
11.10.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021)
11.10.5 Osiris Therapeutics Recent Development
11.11 Vcanbio
11.11.1 Vcanbio Company Details
11.11.2 Vcanbio Business Overview
11.11.3 Vcanbio Regenerative Medicine Introduction
11.11.4 Vcanbio Revenue in Regenerative Medicine Business (2016-2021)
11.11.5 Vcanbio Recent Development
11.12 Gamida Cell
11.12.1 Gamida Cell Company Details
11.12.2 Gamida Cell Business Overview
11.12.3 Gamida Cell Regenerative Medicine Introduction
11.12.4 Gamida Cell Revenue in Regenerative Medicine Business (2016-2021)
11.12.5 Gamida Cell Recent Development
11.13 Golden Meditech
11.13.1 Golden Meditech Company Details
11.13.2 Golden Meditech Business Overview
11.13.3 Golden Meditech Regenerative Medicine Introduction
11.13.4 Golden Meditech Revenue in Regenerative Medicine Business (2016-2021)
11.13.5 Golden Meditech Recent Development
11.14 Cytori
11.14.1 Cytori Company Details
11.14.2 Cytori Business Overview
11.14.3 Cytori Regenerative Medicine Introduction
11.14.4 Cytori Revenue in Regenerative Medicine Business (2016-2021)
11.14.5 Cytori Recent Development
11.15 Celgene
11.15.1 Celgene Company Details
11.15.2 Celgene Business Overview
11.15.3 Celgene Regenerative Medicine Introduction
11.15.4 Celgene Revenue in Regenerative Medicine Business (2016-2021)
11.15.5 Celgene Recent Development
11.16 Vericel Corporation
11.16.1 Vericel Corporation Company Details
11.16.2 Vericel Corporation Business Overview
11.16.3 Vericel Corporation Regenerative Medicine Introduction
11.16.4 Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021)
11.16.5 Vericel Corporation Recent Development
11.17 Guanhao Biotech
11.17.1 Guanhao Biotech Company Details
11.17.2 Guanhao Biotech Business Overview
11.17.3 Guanhao Biotech Regenerative Medicine Introduction
11.17.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021)
11.17.5 Guanhao Biotech Recent Development
11.18 Mesoblast
11.18.1 Mesoblast Company Details
11.18.2 Mesoblast Business Overview
11.18.3 Mesoblast Regenerative Medicine Introduction
11.18.4 Mesoblast Revenue in Regenerative Medicine Business (2016-2021)
11.18.5 Mesoblast Recent Development
11.18 Stemcell Technologies
.1 Stemcell Technologies Company Details
.2 Stemcell Technologies Business Overview
.3 Stemcell Technologies Regenerative Medicine Introduction
.4 Stemcell Technologies Revenue in Regenerative Medicine Business (2016-2021)
.5 Stemcell Technologies Recent Development
11.20 Bellicum Pharmaceuticals
11.20.1 Bellicum Pharmaceuticals Company Details
11.20.2 Bellicum Pharmaceuticals Business Overview
11.20.3 Bellicum Pharmaceuticals Regenerative Medicine Introduction
11.20.4 Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2016-2021)
11.20.5 Bellicum Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cell Therapy
    Table 3. Key Players of Tissue Engineering
    Table 4. Key Players of Biomaterial
    Table 5. Key Players of Other
    Table 6. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Regenerative Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Regenerative Medicine Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Regenerative Medicine Market Share by Regions (2016-2021)
    Table 10. Global Regenerative Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Regenerative Medicine Market Share by Regions (2022-2027)
    Table 12. Regenerative Medicine Market Trends
    Table 13. Regenerative Medicine Market Drivers
    Table 14. Regenerative Medicine Market Challenges
    Table 15. Regenerative Medicine Market Restraints
    Table 16. Global Regenerative Medicine Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Regenerative Medicine Market Share by Players (2016-2021)
    Table 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020)
    Table 19. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Regenerative Medicine Product Solution and Service
    Table 23. Date of Enter into Regenerative Medicine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Regenerative Medicine Revenue Market Share by Type (2016-2021)
    Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Regenerative Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Regenerative Medicine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Regenerative Medicine Revenue Market Share by Application (2016-2021)
    Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Regenerative Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
    Table 63. DePuy Synthes Company Details
    Table 64. DePuy Synthes Business Overview
    Table 65. DePuy Synthes Regenerative Medicine Product
    Table 66. DePuy Synthes Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 67. DePuy Synthes Recent Development
    Table 68. Medtronic Company Details
    Table 69. Medtronic Business Overview
    Table 70. Medtronic Regenerative Medicine Product
    Table 71. Medtronic Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 72. Medtronic Recent Development
    Table 73. ZimmerBiomet Company Details
    Table 74. ZimmerBiomet Business Overview
    Table 75. ZimmerBiomet Regenerative Medicine Product
    Table 76. ZimmerBiomet Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 77. ZimmerBiomet Recent Development
    Table 78. Stryker Company Details
    Table 79. Stryker Business Overview
    Table 80. Stryker Regenerative Medicine Product
    Table 81. Stryker Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 82. Stryker Recent Development
    Table 83. Acelity Company Details
    Table 84. Acelity Business Overview
    Table 85. Acelity Regenerative Medicine Product
    Table 86. Acelity Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 87. Acelity Recent Development
    Table 88. MiMedx Group Company Details
    Table 89. MiMedx Group Business Overview
    Table 90. MiMedx Group Regenerative Medicine Product
    Table 91. MiMedx Group Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 92. MiMedx Group Recent Development
    Table 93. Organogenesis Company Details
    Table 94. Organogenesis Business Overview
    Table 95. Organogenesis Regenerative Medicine Product
    Table 96. Organogenesis Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 97. Organogenesis Recent Development
    Table 98. UniQure Company Details
    Table 99. UniQure Business Overview
    Table 100. UniQure Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 101. UniQure Recent Development
    Table 102. Cellular Dynamics International Company Details
    Table 103. Cellular Dynamics International Business Overview
    Table 104. Cellular Dynamics International Regenerative Medicine Product
    Table 105. Cellular Dynamics International Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 106. Cellular Dynamics International Recent Development
    Table 107. Osiris Therapeutics Company Details
    Table 108. Osiris Therapeutics Business Overview
    Table 109. Osiris Therapeutics Regenerative Medicine Product
    Table 110. Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 111. Osiris Therapeutics Recent Development
    Table 112. Vcanbio Company Details
    Table 113. Vcanbio Business Overview
    Table 114. Vcanbio Regenerative Medicine Product
    Table 115. Vcanbio Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 116. Vcanbio Recent Development
    Table 117. Gamida Cell Company Details
    Table 118. Gamida Cell Business Overview
    Table 119. Gamida Cell Regenerative Medicine Product
    Table 120. Gamida Cell Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 121. Gamida Cell Recent Development
    Table 122. Golden Meditech Company Details
    Table 123. Golden Meditech Business Overview
    Table 124. Golden Meditech Regenerative Medicine Product
    Table 125. Golden Meditech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 126. Golden Meditech Recent Development
    Table 127. Cytori Company Details
    Table 128. Cytori Business Overview
    Table 129. Cytori Regenerative Medicine Product
    Table 130. Cytori Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 131. Cytori Recent Development
    Table 132. Celgene Company Details
    Table 133. Celgene Business Overview
    Table 134. Celgene Regenerative Medicine Product
    Table 135. Celgene Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 136. Celgene Recent Development
    Table 137. Vericel Corporation Company Details
    Table 138. Vericel Corporation Business Overview
    Table 139. Vericel Corporation Regenerative Medicine Product
    Table 140. Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 141. Vericel Corporation Recent Development
    Table 142. Guanhao Biotech Company Details
    Table 143. Guanhao Biotech Business Overview
    Table 144. Guanhao Biotech Regenerative Medicine Product
    Table 145. Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 146. Guanhao Biotech Recent Development
    Table 147. Mesoblast Company Details
    Table 148. Mesoblast Business Overview
    Table 149. Mesoblast Regenerative Medicine Product
    Table 150. Mesoblast Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 151. Mesoblast Recent Development
    Table 152. Stemcell Technologies Company Details
    Table 153. Stemcell Technologies Business Overview
    Table 154. Stemcell Technologies Regenerative Medicine Product
    Table 155. Stemcell Technologies Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 156. Stemcell Technologies Recent Development
    Table 157. Bellicum Pharmaceuticals Company Details
    Table 158. Bellicum Pharmaceuticals Business Overview
    Table 159. Bellicum Pharmaceuticals Regenerative Medicine Product
    Table 160. Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
    Table 161. Bellicum Pharmaceuticals Recent Development
    Table 162. Research Programs/Design for This Report
    Table 163. Key Data Information from Secondary Sources
    Table 164. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Regenerative Medicine Market Share by Type: 2020 VS 2027
    Figure 2. Cell Therapy Features
    Figure 3. Tissue Engineering Features
    Figure 4. Biomaterial Features
    Figure 5. Other Features
    Figure 6. Global Regenerative Medicine Market Share by Application: 2020 VS 2027
    Figure 7. Dermatology Case Studies
    Figure 8. Cardiovascular Case Studies
    Figure 9. CNS Case Studies
    Figure 10. Orthopedic Case Studies
    Figure 11. Others Case Studies
    Figure 12. Regenerative Medicine Report Years Considered
    Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Regenerative Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Regenerative Medicine Market Share by Regions: 2020 VS 2027
    Figure 16. Global Regenerative Medicine Market Share by Regions (2022-2027)
    Figure 17. Global Regenerative Medicine Market Share by Players in 2020
    Figure 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2020
    Figure 20. Global Regenerative Medicine Revenue Market Share by Type (2016-2021)
    Figure 21. Global Regenerative Medicine Revenue Market Share by Type (2022-2027)
    Figure 22. North America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Regenerative Medicine Market Share by Type (2016-2027)
    Figure 24. North America Regenerative Medicine Market Share by Application (2016-2027)
    Figure 25. North America Regenerative Medicine Market Share by Country (2016-2027)
    Figure 26. United States Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Regenerative Medicine Market Share by Type (2016-2027)
    Figure 30. Europe Regenerative Medicine Market Share by Application (2016-2027)
    Figure 31. Europe Regenerative Medicine Market Share by Country (2016-2027)
    Figure 32. Germany Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Regenerative Medicine Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Regenerative Medicine Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Regenerative Medicine Market Share by Region (2016-2027)
    Figure 42. China Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Regenerative Medicine Market Share by Type (2016-2027)
    Figure 50. Latin America Regenerative Medicine Market Share by Application (2016-2027)
    Figure 51. Latin America Regenerative Medicine Market Share by Country (2016-2027)
    Figure 52. Mexico Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Regenerative Medicine Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Regenerative Medicine Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Regenerative Medicine Market Share by Country (2016-2027)
    Figure 58. Turkey Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. DePuy Synthes Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 62. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 63. ZimmerBiomet Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 64. Stryker Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 65. Acelity Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 66. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 67. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 68. UniQure Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 69. Cellular Dynamics International Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 70. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 71. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 72. Gamida Cell Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 73. Golden Meditech Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 74. Cytori Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 75. Celgene Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 76. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 77. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 78. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 79. Stemcell Technologies Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 80. Bellicum Pharmaceuticals Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Home Healthcare Market Size Study and Regional Forecasts 2019 2025
Global and United States Home Healthcare Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Othe-2A197
Sun Oct 03 04:59:39 UTC 2021

Add to Cart

China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report Forecast 2021 2027
China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6U7133
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Apheresis Machines Market Report Forecast 2021 2027
China Apheresis Machines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6233
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Anti snoring Devices Market Report Forecast 2021 2027
China Anti-snoring Devices Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-0K470
Sat Oct 02 00:00:00 UTC 2021

Add to Cart